Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Credit Suisse Healthcare Conference Transcript

Nov 08, 2022 / 08:50PM GMT
Release Date Price: $14.25 (+0.64%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

Our next presentation, we have Maravai. We're lucky to have with us today, Kevin Herde, Chief Financial Officer; and Brian Neel, Chief Operating Officer. I'm Dan Leonard, I cover the life sciences industry for Credit Suisse. Kevin and Brian, thank you for coming.

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Thanks, Dan.

Questions & Answers

Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

I was hoping to start off the fireside with a brief overview of Maravai for folks who might not be familiar?

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Yes, certainly happy to do that. So Maravai LifeSciences, obviously, a life sciences company, really focused in on 2 segments, our Nucleic Acid production segment and our Biologics Safety Testing segment.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot